Loperamide does not promote central analgesia because it cannot readily cross the blood-brain barrier
the verdict
SUPPORTED
the evidence backs this
confidence 86/100
Loperamide acts as a peripherally restricted opioid because active efflux transporters at the blood-brain barrier normally prevent it from entering the central nervous system.
Evidence for · 3
Competitive Substrates for P-Glycoprotein and Organic Anion Protein Transporters Differentially Reduce Blood Organ Transport of Fentanyl and Loperamide: Pharmacokinetics and Pharmacodynamics in Sprague Dawley Rats
2009 · cited by 45
Demonstrates that loperamide's limited central nervous system penetration and low brain-to-plasma partitioning are normally enforced by active transport mechanisms.
See more details
More for · 2
Proteasome inhibition protects blood–brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer’s disease model
2023 · cited by 24
Shows that loperamide's lack of central effects under normal conditions is due to P-glycoprotein efflux at the blood-brain barrier, which fails only when transport is impaired.
Peripherally mediated opioid combination therapy in mouse and pig.
2025 · cited by 1
Identifies loperamide as a peripherally restricted mu-opioid agonist that exerts its actions without central nervous system side effects.